FDA Inspection 1254934 - Bioreliance Corporation - November 22, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Bioreliance Corporation, with an inspection on November 22, 2024, issued by the Baltimore District Office, covering biologics.

Company: Bioreliance Corporation
Inspection Date: November 22, 2024
Product Type: Biologics
Office: Baltimore District Office

Open in Dashboard

ID · 7941bc6b-db19-4266-b05d-af8a19fbde51

Violation Codes1

21 CFR 211.192

Full citation text and observation details available on the Dashboard.